American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey.
Psychedelic Medicine March 1, 2024 Brian S. Barnett, Miranda Arakelian, David Beebe et al. 28 citations
Psilocybin, a classic hallucinogen, may eventually be approved by the United States Food and Drug Administration for treatment-resistant depression. However, we are aware of only one published national survey of American psychiatrists regarding their opinions about hallucinogens and hallucinogen-assisted therapy, conducted by our group in 2016. Here, we report a repeat survey, using virtually...
DOI: 10.1089/psymed.2023.0036 (opens in new tab)
Full text (opens in new tab)
Psychedelic therapy
Psychiatric research
Hallucinogen studies
Medical attitudes
+4